牛牛AI助理已提取核心訊息
Merck & Co. Inc. officer Jennifer Zachary is set to sell 49,499 shares of the company's common stock on February 2, 2024, with an aggregate market value of approximately $6,284,779. The shares to be sold were acquired through restricted stock vesting and the exercise of options under a registered plan, with acquisition dates ranging from February 26, 2021, to February 2, 2024. The most recent acquisition involved the exercise of options for 19,417 shares on the same date as the planned sale, with payment made in cash. The transactions over the past few months do not report any sales of securities.
Merck & Co. Inc. officer Jennifer Zachary is set to sell 49,499 shares of the company's common stock on February 2, 2024, with an aggregate market value of approximately $6,284,779. The shares to be sold were acquired through restricted stock vesting and the exercise of options under a registered plan, with acquisition dates ranging from February 26, 2021, to February 2, 2024. The most recent acquisition involved the exercise of options for 19,417 shares on the same date as the planned sale, with payment made in cash. The transactions over the past few months do not report any sales of securities.
默沙東公司公司高管詹妮弗·扎卡里定於2024年2月2日出售該公司49,499股普通股，總市值約爲6,284,779美元。待出售的股票是通過限制性股票歸屬和根據註冊計劃行使期權收購的，收購日期從2021年2月26日到2024年2月2日不等。最近的收購涉及在計劃出售的同一天行使19,417股股票的期權，並以現金支付。過去幾個月的交易沒有報告任何證券的銷售情況。
默沙東公司公司高管詹妮弗·扎卡里定於2024年2月2日出售該公司49,499股普通股，總市值約爲6,284,779美元。待出售的股票是通過限制性股票歸屬和根據註冊計劃行使期權收購的，收購日期從2021年2月26日到2024年2月2日不等。最近的收購涉及在計劃出售的同一天行使19,417股股票的期權，並以現金支付。過去幾個月的交易沒有報告任何證券的銷售情況。
有用
沒用